The statement addresses a public issue, specifically the FDA's rejection of an application for MDMA-assisted therapy for PTSD, and references a peer-reviewed study, making it a substantive engagement with public concerns.
- The statement does not appear to cause harm with words and actions. It presents factual information about the FDA's decision and the study's findings without inflammatory language. [+1]Principle 1:I will strive to do no harm with my words and actions.
- The statement promotes understanding by providing information about the potential benefits of MDMA-assisted therapy for PTSD, which could foster empathy and compassion for individuals suffering from PTSD. [+2]Principle 3:I will use my words and actions to promote understanding, empathy, and compassion.
- The statement does not engage in personal attacks or ad hominem arguments. It focuses on the FDA's decision and the study's results, maintaining a constructive tone. [+1]Principle 4:I will engage in constructive criticism and dialogue with those in disagreement and will not engage in personal attacks or ad hominem arguments.
- By highlighting a potentially beneficial treatment for PTSD, the statement uses its influence to inform the public about an important health issue, contributing to societal betterment. [+2]Principle 6:I will use my influence for the betterment of society.
- The statement upholds the principles of free speech and uses the platform responsibly by sharing relevant information about a public health issue with integrity. [+2]Principle 7:I will uphold the principles of free speech and use my platform responsibly and with integrity.